We just published s paper in Therapeutic Advances in Gastroenterology “Aloe barbadensis Mill. extract improves symptoms in IBS with diarrhea (IBS-D) in “: A post‑hoc analysis of two randomized double-blind controlled studies” Bani Ghei Ahluwalia and...
Calmino group AB is proud to announce that PROIBS® has just been launched in a new country within Europe. This time it’s the company Alfasigma Schweiz AG who launched PROIBS® in Switzerland. By launching PROIBS® in the heart of Europe, we look forward to expand our...
We are proud to be presenting our latest research at the Virtual Swedish Gastroenterology Conference, “Svenska Gastrodagarna, 2021”! Don’t miss out our Poster titled “Aloe barbadensis Mill. extract improves symptoms in IBS with diarrhea...
We are happy to announce that PROIBS® will soon be available in a new country in Europe! Calmino Group is proud to announce that we have just signed a new agreement for the distribution of PROIBS® as a Medical Device in another country in Europe. This agreement...
With PROIBS® turning 10 years old in a time where the world is still facing an unprecedented global health crisis, it is important for us to reflect on the past, and more importantly, to focus on the future. Our growth over the years has been a cumulative outcome of...
On TV! Launching PROIBS® in a new country in the midst of a pandemic has been eventful for Calmino to say the least. But there is cause for optimism, and technology will be key. It is exciting for Calmino group to announce that PROIBS® television commercials has been...
Recent Comments